ATAZANAVIR (ATAZANAVIR SULFATE) — all Canadian products
17 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ATAZANAVIR (ATAZANAVIR SULFATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02479249 | APO-ATAZANAVIR | APOTEX INC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG | Approved | |
| 02479265 | APO-ATAZANAVIR | APOTEX INC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG | Approved | |
| 02479257 | APO-ATAZANAVIR | APOTEX INC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG | Approved | |
| 02456893 | MYLAN-ATAZANAVIR | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG | Marketed | |
| 02456877 | MYLAN-ATAZANAVIR | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG | Marketed | |
| 02456885 | MYLAN-ATAZANAVIR | MYLAN PHARMACEUTICALS ULC | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG | Marketed | |
| 02443821 | TEVA-ATAZANAVIR | TEVA CANADA LIMITED | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG | Marketed | |
| 02443791 | TEVA-ATAZANAVIR | TEVA CANADA LIMITED | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG | Marketed | |
| 02443813 | TEVA-ATAZANAVIR | TEVA CANADA LIMITED | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG | Marketed | |
| 02446731 | EVOTAZ | BRISTOL-MYERS SQUIBB CANADA | Tablet | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG; COBICISTAT 150 MG | Cancelled Post Market | |
| 02513129 | JAMP ATAZANAVIR | JAMP PHARMA CORPORATION | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG | Dormant | |
| 02513102 | JAMP ATAZANAVIR | JAMP PHARMA CORPORATION | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG | Dormant | |
| 02513110 | JAMP ATAZANAVIR | JAMP PHARMA CORPORATION | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG | Dormant | |
| 02248610 | REYATAZ | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG | Cancelled Post Market | |
| 02248609 | REYATAZ | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 100 MG | Cancelled Pre Market | |
| 02294176 | REYATAZ | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 300 MG | Cancelled Post Market | |
| 02248611 | REYATAZ | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG | Cancelled Post Market |
Browse other molecules: